Urinary bladder neoplasm
MONDO:0004987A benign or malignant, primary or metastatic neoplasm of the bladder. - 2003
Also known as: bladder neoplasm, bladder tumor, bladder tumors, bladder tumour, bladder tumours, neoplasm of bladder, neoplasm of the bladder, neoplasm of the urinary bladder
2109 clinical trials for this condition and its sub-types, 65 tagged with Urinary bladder neoplasm itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Urinary bladder neoplasm
-
Urinary bladder cancer 40 trials · 686 incl. sub-types
9 sub-types
- Urinary bladder carcinoma 394 trials · 673 incl. sub-types Sub-types →
- Urachus cancer 3 trials · 6 incl. sub-types Sub-types →
- Bladder dome cancer 0 trials Sub-types →
- Bladder lateral wall cancer 0 trials
- Bladder lymphoma 0 trials
- Bladder neck cancer 0 trials
- Bladder sarcoma 0 trials
- Urinary bladder anterior wall cancer 0 trials
- Urinary bladder posterior wall cancer 0 trials
-
Bladder flat intraepithelial lesion 0 trials · 30 incl. sub-types
1 sub-type
- Bladder carcinoma in situ 30 trials
-
Bladder papillary urothelial neoplasm 1 trial · 13 incl. sub-types
2 sub-types
-
Bladder benign neoplasm 0 trials
4 sub-types
- Bladder leiomyoma 0 trials
- Bladder squamous papilloma 0 trials
- Bladder urothelial papilloma 0 trials Sub-types →
- Nephrogenic adenoma of urinary bladder 0 trials
-
Urinary bladder villous adenoma 0 trials
Most studied deeper sub-types
-
New bladder cancer drug delivered directly into bladder shows early promise
Disease control Stopped earlyThis early-phase trial tested enfortumab vedotin, a drug placed directly into the bladder via a catheter, in 37 people with a type of bladder cancer that did not respond to standard BCG therapy. The main goals were to check safety and side effects, and to see if the drug could he…
Phase 1 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Experimental bladder cancer drug shows promise but trial halted early
Disease control Stopped earlyThis study tested an experimental drug called enfortumab vedotin, alone or with other cancer drugs, in people with advanced bladder or urinary tract cancer. The goal was to see if the drug could shrink tumors and control the disease. The trial included 348 participants but was te…
Phase 1/2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Bladder cancer drug combo trial halted early – what does it mean?
Disease control Stopped earlyThis phase 3 trial tested whether adding nivolumab (an immunotherapy drug) to standard BCG treatment could help people with high-risk bladder cancer that came back after BCG alone. Only 13 people enrolled before the study was stopped early, so we don't have clear results on wheth…
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 26, 2026 18:24 UTC